ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
0.00%
Dow Jones
38,675.68
0.00%
US Dollar vs MXN
16.92265
-0.36%
Brent Oil
83.365
0.29%
Bitcoin
63,490.68
-0.79%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Hoth Therapeutics Inc (HOTH)

  7. Hoth Therapeutics Inc (HOTH) Noticias

HOTH Hoth Therapeutics Inc

1.21
0.00 (0.00%)
Pre Mercado
Última actualización: 06:46:04
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Hoth Therapeutics Inc HOTH NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 1.21 06:46:04
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.21
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
01/5/202407:00PRNUSHoth Therapeutics to Attend EF Hutton Annual Global..
27/3/202413:00PRNUSHoth Therapeutics Announces Exercise of Warrants for $4.2..
27/3/202407:27PRNUSHoth Therapeutics' Wholly Owned Subsidiary Merveille.ai,..
19/3/202407:21PRNUSHoth Therapeutics Announces Positive Data In Completed Study..
29/2/202407:38PRNUSHoth Therapeutics Retains Venable LLP to Expand Its Patent..
26/2/202407:11PRNUSHoth Therapeutics Engages Altasciences to Perform Key Study..
13/2/202410:45PRNUSHoth Therapeutics to Attend BIO CEO and Investor Conference,..
18/1/202407:20PRNUSHoth Therapeutics Announces it Received FDA Approval to..
09/1/202414:03EDGAR2Form 8-K - Current report
08/1/202416:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202416:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202416:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202416:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/12/202307:21PRNUSHoth Therapeutics Announces Expansion of FDA Cleared..
05/12/202307:33PRNUSHoth Therapeutics Announces it Has Successfully Completed..
14/11/202307:37PRNUSHoth Therapeutics Announces Successful Completion of Pre-IND..
13/11/202315:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202307:00PRNUSHoth Therapeutics to Present at NobleCon's 19th Annual..
05/10/202309:03PRNUSHoth Therapeutics Announces Merveille.ai Artificial..
05/10/202307:15EDGAR2Form 8-K - Current report
02/10/202307:33PRNUSFDA Grants Hoth Therapeutics Pre-IND Meeting for HT-KIT,..
15/9/202315:15EDGAR2Form 8-K - Current report
15/9/202313:38PRNUSHoth Therapeutics Announces Closing of $2.89 Million..
14/9/202316:24EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
13/9/202312:43PRNUSHoth Therapeutics Announces $2.89 Million Registered Direct..
13/9/202307:16PRNUSHoth Therapeutics Announces Positive Results Killing Cancer..
11/9/202309:04PRNUSHoth Therapeutics Announces FDA Accepts Pre-Investigational..
06/9/202307:12PRNUSHoth Therapeutics Announces Positive Final Results from..
21/8/202316:10EDGAR2Form 8-K - Current report
21/8/202316:00EDGAR2Form S-8 - Securities to be offered to employees in employee..
11/8/202315:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202307:13PRNUSHoth Therapeutics Announces Positive Preclinical End Point..
25/7/202307:12PRNUSHoth Therapeutics Announces Major Milestone of First Patient..
19/7/202307:02PRNUSHoth Therapeutics Receives Protocol Approval for HT-001..
18/7/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202307:12PRNUSHoth Therapeutics Announces IRB Approval for FDA Cleared..
06/6/202307:02PRNUSHoth Therapeutics Announces Positive Preclinical Results of..
12/5/202307:38PRNUSHoth Therapeutics and Algorithm Sciences Terminate Letter of..

Su Consulta Reciente

NASDAQ
HOTH
Hoth Therapeutics
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados